NCT03241173 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- up to 17.4 months
- Other-event reporting threshold
- 5%
Treatment-emergent adverse events, defined as any adverse events either reported for the first time or the worsening of pre-existing events after the first dose of study drug, have been reported.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Phase 1, Dose Escalation: INCAGN01949 70 mg + Nivolumab 240 mg | 3 / 4 | 4 / 4 | 3 / 4 |
| Phase 1, Dose Escalation: INCAGN01949 200 mg + Nivolumab 240 mg | 1 / 4 | 4 / 4 | 2 / 4 |
| Phase 1, Dose Escalation: INCAGN01949 350 mg + Nivolumab 240 mg | 4 / 5 | 5 / 5 | 4 / 5 |
| Phase 1, Dose Escalation: INCAGN01949 700 mg + Nivolumab 240 mg | 3 / 5 | 5 / 5 | 4 / 5 |
| Phase 1, Dose Escalation: INCAGN01949 70 mg + Ipilimumab 1 mg/kg | 2 / 4 | 4 / 4 | 2 / 4 |
| Phase 1, Dose Escalation: INCAGN01949 200 mg + Ipilimumab 1 mg/kg | 2 / 5 | 5 / 5 | 2 / 5 |
| Phase 1, Dose Escalation: INCAGN01949 350 mg + Ipilimumab 1 mg/kg | 2 / 4 | 4 / 4 | 3 / 4 |
| Phase 1, Dose Escalation: INCAGN01949 700 mg + Ipilimumab 1 mg/kg | 1 / 3 | 3 / 3 | 1 / 3 |
| Phase 1, Safety Expansion: INCAGN01949 70 mg + Nivolumab 240 mg | 4 / 6 | 6 / 6 | 5 / 6 |
| Phase 1, Safety Expansion: INCAGN01949 200 mg + Nivolumab 240 mg | 3 / 6 | 6 / 6 | 4 / 6 |
| Phase 1, Safety Expansion: INCAGN01949 350 mg + Nivolumab 240 mg | 3 / 6 | 6 / 6 | 3 / 6 |
| Total | 28 / 52 | 52 / 52 | 33 / 52 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Adrenal insufficiency
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Cholangitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Cholestasis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Coronary artery disease
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Dermatitis contact
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Dysphagia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 3
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 3
- term
- Dyspnoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Failure to thrive
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Abdominal discomfort
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 4
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 5
- num Events
- 2
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG011
- num Affected
- 10
- num At Risk
- 52
- num Events
- 12
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 3
- num At Risk
- 52
- num Events
- 3
- term
- Abdominal pain lower
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 3
- num At Risk
- 52
- num Events
- 4
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 4
- num At Risk
- 52
- num Events
- 4
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Amnesia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 2
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG011
- num Affected
- 5
- num At Risk
- 52
- num Events
- 6
- term
- Amylase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 5
- num At Risk
- 52
- num Events
- 5
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Angular cheilitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Animal bite
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Animal scratch
Complete source fields
- description
- Treatment-emergent adverse events, defined as any adverse events either reported for the first time or the worsening of pre-existing events after the first dose of study drug, have been reported.
- event Groups
- deaths Num Affected
- 3
- deaths Num At Risk
- 4
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 70 milligrams (mg) every 2 weeks (Q2W) beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 1 Day 1, administered as intravenous (IV) infusions.
- id
- EG000
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 3
- serious Num At Risk
- 4
- title
- Phase 1, Dose Escalation: INCAGN01949 70 mg + Nivolumab 240 mg
- deaths Num Affected
- 2
- deaths Num At Risk
- 4
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 200 mg Q2W beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG001
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 1
- serious Num At Risk
- 4
- title
- Phase 1, Dose Escalation: INCAGN01949 200 mg + Nivolumab 240 mg
- deaths Num Affected
- 4
- deaths Num At Risk
- 5
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 350 mg Q2W beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG002
- other Num Affected
- 5
- other Num At Risk
- 5
- serious Num Affected
- 4
- serious Num At Risk
- 5
- title
- Phase 1, Dose Escalation: INCAGN01949 350 mg + Nivolumab 240 mg
- deaths Num Affected
- 4
- deaths Num At Risk
- 5
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 700 mg Q2W beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG003
- other Num Affected
- 5
- other Num At Risk
- 5
- serious Num Affected
- 3
- serious Num At Risk
- 5
- title
- Phase 1, Dose Escalation: INCAGN01949 700 mg + Nivolumab 240 mg
- deaths Num Affected
- 2
- deaths Num At Risk
- 4
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 70 mg Q2W beginning on Cycle 1 Day 1, followed by ipilimumab 1 mg/kilogram (kg) every 6 weeks (Q6W) beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG004
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 2
- serious Num At Risk
- 4
- title
- Phase 1, Dose Escalation: INCAGN01949 70 mg + Ipilimumab 1 mg/kg
- deaths Num Affected
- 2
- deaths Num At Risk
- 5
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 200 mg Q2W beginning on Cycle 1 Day 1, followed by ipilimumab 1 mg/kg Q6W beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG005
- other Num Affected
- 5
- other Num At Risk
- 5
- serious Num Affected
- 2
- serious Num At Risk
- 5
- title
- Phase 1, Dose Escalation: INCAGN01949 200 mg + Ipilimumab 1 mg/kg
- deaths Num Affected
- 3
- deaths Num At Risk
- 4
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 350 mg Q2W beginning on Cycle 1 Day 1, followed by ipilimumab 1 mg/kg Q6W beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG006
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 2
- serious Num At Risk
- 4
- title
- Phase 1, Dose Escalation: INCAGN01949 350 mg + Ipilimumab 1 mg/kg
- deaths Num Affected
- 1
- deaths Num At Risk
- 3
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 700 mg Q2W beginning on Cycle 1 Day 1, followed by ipilimumab 1 mg/kg Q6W beginning on Cycle 1 Day 1, administered as IV infusions.
- id
- EG007
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 1
- serious Num At Risk
- 3
- title
- Phase 1, Dose Escalation: INCAGN01949 700 mg + Ipilimumab 1 mg/kg
- deaths Num Affected
- 5
- deaths Num At Risk
- 6
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 70 mg Q2W beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 3 Day 1, administered as IV infusions.
- id
- EG008
- other Num Affected
- 6
- other Num At Risk
- 6
- serious Num Affected
- 4
- serious Num At Risk
- 6
- title
- Phase 1, Safety Expansion: INCAGN01949 70 mg + Nivolumab 240 mg
- deaths Num Affected
- 4
- deaths Num At Risk
- 6
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 200 mg Q2W beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 3 Day 1, administered as IV infusions.
- id
- EG009
- other Num Affected
- 6
- other Num At Risk
- 6
- serious Num Affected
- 3
- serious Num At Risk
- 6
- title
- Phase 1, Safety Expansion: INCAGN01949 200 mg + Nivolumab 240 mg
- deaths Num Affected
- 3
- deaths Num At Risk
- 6
- description
- Participants with advanced or metastatic select solid tumors received INCAGN01949 350 mg Q2W beginning on Cycle 1 Day 1, followed by nivolumab 240 mg Q2W beginning on Cycle 3 Day 1, administered as IV infusions.
- id
- EG010
- other Num Affected
- 6
- other Num At Risk
- 6
- serious Num Affected
- 3
- serious Num At Risk
- 6
- title
- Phase 1, Safety Expansion: INCAGN01949 350 mg + Nivolumab 240 mg
- deaths Num Affected
- 33
- deaths Num At Risk
- 52
- description
- Total
- id
- EG011
- other Num Affected
- 52
- other Num At Risk
- 52
- serious Num Affected
- 28
- serious Num At Risk
- 52
- title
- Total
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Abdominal discomfort
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 4
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 5
- num Events
- 2
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG011
- num Affected
- 10
- num At Risk
- 52
- num Events
- 12
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 3
- num At Risk
- 52
- num Events
- 3
- term
- Abdominal pain lower
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 3
- num At Risk
- 52
- num Events
- 4
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 4
- num At Risk
- 52
- num Events
- 4
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Amnesia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 2
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG011
- num Affected
- 5
- num At Risk
- 52
- num Events
- 6
- term
- Amylase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 5
- num At Risk
- 52
- num Events
- 5
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Angular cheilitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Animal bite
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Animal scratch
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Adrenal insufficiency
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Cholangitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Cholestasis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Coronary artery disease
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Dermatitis contact
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Dysphagia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 4
- num Events
- 3
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 3
- term
- Dyspnoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 22
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- term
- Failure to thrive
- time Frame
- up to 17.4 months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle